Oncospace

Oncospace is a Baltimore-based company that specializes in cloud-native, AI-powered data analytics solutions for the radiation oncology community. Founded in 2018 with intellectual property licensed from Johns Hopkins University, Oncospace aims to enhance patient outcomes and clinical practice efficiency through advanced data-driven technologies. The company offers two main AI-driven products. The Gateway tool assists users of Philips Pinnacle in converting patient archives to modern treatment planning systems, ensuring seamless migration in clinical workflows. The Predictive Plan Quality and Feasibility Solution utilizes machine learning to analyze clinical treatment plans, providing insights that improve treatment precision and efficiency. Oncospace's team includes medical physicists, data scientists, and radiation oncology innovators. In 2025, the company was acquired by Sun Nuclear, integrating its AI solutions into Sun Nuclear’s radiation therapy quality assurance strategy. Oncospace is dedicated to optimizing radiation oncology treatment planning and outcomes.

• Employees 4
• Founded 2019
• Total Funding $925000